[Perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection (2nd Edition)]

    Insights

    This study updates the perinatal and neonatal management plan for preventing and controlling SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection. The revised plan incorporates new clinical findings for pregnant women and newborns.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Public Health

    Background:

    • The global outbreak of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection, beginning in late December 2019, has necessitated rapid development of clinical guidelines.
    • Initial management strategies for perinatal and neonatal SARS-CoV-2 infection were established in January 2020.
    • Evolving understanding of SARS-CoV-2, including cases in pregnant individuals and neonates, requires updated clinical guidance.

    Purpose of the Study:

    • To revise and update the initial management plan for preventing and controlling SARS-CoV-2 infection in the perinatal and neonatal periods.
    • To provide enhanced clinical guidance based on emerging data and practical experience with SARS-CoV-2 in vulnerable populations.
    • To ensure healthcare providers have the most current recommendations for managing SARS-CoV-2 in pregnant women and newborns.

    Main Methods:

    • The Working Group for the Prevention and Control of Neonatal SARS-CoV-2 Infection in the Perinatal Period reviewed clinical data and practical experiences.
    • The first edition of the management plan, implemented for three weeks, was critically assessed.
    • Evidence and clinical observations regarding SARS-CoV-2 in pregnant women and neonates informed the revisions.

    Main Results:

    • A second edition of the perinatal and neonatal management plan for SARS-CoV-2 infection has been developed.
    • The updated plan reflects a greater understanding of the virus's impact on pregnant women and newborns.
    • The revised guidelines aim to improve the prevention and control of SARS-CoV-2 in clinical settings.

    Conclusions:

    • Continuous updates to clinical management plans are crucial for addressing novel infectious diseases like SARS-CoV-2.
    • The second edition provides updated recommendations for the prevention and control of SARS-CoV-2 in perinatal and neonatal care.
    • This revised plan supports evidence-based practice and enhances the management of SARS-CoV-2 in high-risk populations.

    Related Concept Videos

    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
    3.3K
    Transmission-based Precautions II: Airborne and Protective Environment01:25

    Transmission-based Precautions II: Airborne and Protective Environment

    Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
    Airborne precautions:
    Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
    1.8K
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    675
    Standard Precaution01:26

    Standard Precaution

    Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
    Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
    2.6K
    Healthcare Associated Infections II: Preventive Measures01:22

    Healthcare Associated Infections II: Preventive Measures

    Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
    The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
    3.5K
    Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

    Transmission-based Precautions I: Contact, Enteric, and Droplets

    Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
    Contact Precautions:
    Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
    4.4K